Abstract:Lipin1 participates in numerous cellular processes, including in the dephosphorylation of phosphatidic acid to diacylglycerol and as a co-transcriptional regulator. Iron is also essential in various critical biological processes. Previous studies have shown that compared to normal tissue cells, lipin1 expression and iron metabolism are abnormal in cancer cells. However, the involvement of lipin1 in the regulation of iron metabolism is unknown. In this study, we compared the contents of eight metal ions (potassium, calcium, sodium, magnesium, manganese, zinc, iron and copper) in human hepatoma carcinoma BEL7402 control cells as well as stable cells overexpressing lipin1 by using ICP-AES. Our results showed that only intracellular iron content was significantly decreased by lipin1 overexpression. Meanwhile, we observed that lipin1 overexpression could inhibit cell proliferation, similar to iron chelator deferoxamine. Western blotting showed that the up-regulation of p53-p21-p27 elicited cell cycle G0/G1 arrest in the stable cells overexpressing lipin1. Conversely, after lipin1 was down regulated with siRNA, we found that cell proliferation was promoted, accompanied by an increase in iron content, and the downregulation of p53 and p21. Our data indicate that lipin1 overexpression may cause reduction of intracellular iron content, which could activate the p53-p21-p27 signaling pathways, leading to cell cycle arrest at the G0/G1 phase in the hepatic carcinoma cells. Subsequently, we identified the putative cause for the decrease of the intracellular iron content induced by lipin1 overexpression. Our results suggested that the intracellular iron reduction was due to the increase in the expression of ferroportin, an iron export protein in the stable cells overexpressing lipin1. In contrast, after transfection with lipin1 siRNA, the decreased expression of ferroportin contributed to an increase in the iron content in BEL7402 cells. It was further confirmed that the intracellular iron content was increased after ferroportin was knocked down by siRNA in BEL7402 cells. Taken together, our findings demonstrate for the first time that lipin1 participates in the regulation of iron metabolism in human hepatic carcinoma cells. This suggests that lipin1 may play an important protective role in inhibiting the development of cancer through the reduction of iron content in tumors, which further demonstrates that iron reduction could be a potential strategy of cancer prevention and treatment.

Iron Regulates Cellular Proliferation by Enhancing the Expression of Glucose Transporter GLUT3 in the Liver

Dietary Iron Modulates Hepatic Glucose Homeostasis Via Regulating Gluconeogenesis

Phosphoinositide-3-kinase inhibition elevates ferritin level resulting depletion of labile iron pool and blocking of glioma cell proliferation

Iron Metabolism, Ferroptosis, and Lncrna in Cancer: Knowns and Unknowns

Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool

Integrating Multi-Omics Techniques and in Vitro Experiments Reveals That GLRX3 Regulates the Immune Microenvironment and Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion Through Iron Metabolism Pathways

Iron Depletion Participates in the Suppression of Cell Proliferation Induced by Lipin1 Overexpression.

Iron metabolism gene expression and prognostic features of hepatocellular carcinoma

Iron Regulates the Warburg Effect and Ferroptosis in Colorectal Cancer

Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies.

Response to iron overload in cultured hepatocytes

Effects of iron deprivation on multidrug resistance of leukemic K562 cells.

Liver Cancer Cells Uptake Labile Iron via L-type Calcium Channel to Facilitate the Cancer Cell Proliferation

Growth Inhibition of a Novel Iron Chelator, DpdtC, Against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation

Iron boosts anti-tumor type 1 T-cell responses and anti-PD1 immunotherapy

Iron Overload Induces Hepatic Ferroptosis and Insulin Resistance by Inhibiting the Jak2/stat3/slc7a11 Signaling Pathway

Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy

EGFR Regulates Iron Homeostasis to Promote Cancer Growth Through Redistribution of Transferrin Receptor 1.

Iron as a therapeutic target in chronic liver disease

Advancement of the study on iron metabolism and regulation in tumor cells.

Iron Increases the Susceptibility of Colorectal Cancer Cells to Compound Kushen Injection Via the Decrease of TOP2A and P53